Patient Medication Information: uses, side effects, how to take - Vpriv
What is VPRIV used for?
VPRIV is an enzyme replacement therapy for pediatric and adult patients with type 1 Gaucher disease.
How does VPRIV work?
Gaucher disease is genetic. Patients with Gaucher disease do not produce enough of their own enzyme, glucocerebrosidase, which breaks down a type of lipid (fat) called glucocerebroside. The reduced enzyme levels in patients cause this lipid to collect in white blood cells in some organs including the brain, bone marrow, liver and spleen. Treatment with VPRIV helps replace the low enzyme levels, which helps reduce the lipid deposits.
What are the ingredients in VPRIV?
Medicinal ingredients: velaglucerase alfa. Velaglucerase alfa is an enzyme similar to the naturally occurring human enzyme glucocerebrosidase.
Non-medicinal ingredients: citric acid monohydrate, polysorbate 20, sodium citrate dihydrate, and sucrose.
VPRIV comes in the following dosage forms:
400 U/vial, packed powder for solution for injection. After reconstitution, each vial contains 100 U/mL.
Do not use VPRIV if:
Do not use VPRIV if you are allergic (hypersensitive) to velaglucerase alfa or any of the other nonmedicinal ingredients.
To help avoid side effects and ensure proper use, talk to your healthcare professional before you take VPRIV. Talk about any health conditions or problems you may have, including if you:
- have previously experienced an infusion-related reaction or allergic reaction with other ERT for Gaucher disease.
Hypersensitivity reactions including symptoms consistent with anaphylaxis (a severe allergic reaction) such as a tightening of the airways going into the lungs and shortness of breath have been observed in some patients treated with VPRIV.
As with any intravenous protein product, allergic reactions are possible.
Appropriate medical support should be readily available when VPRIV is administered.
Treatment with VPRIV should be approached with caution in patients who have had an allergic reaction to the active ingredient or the other medicinal ingredients in the drug product or to other enzyme replacement therapy.
If you are treated with VPRIV you may experience side effects during or following an infusion. This is known as an infusion related reaction and can sometimes be severe.
Infusion related reactions include headache, dizziness, low or high blood pressure, nausea, tiredness, and fever. If you have an infusion-related reaction, tell your doctor immediately.
If you have an infusion-related reaction you may be given additional medicines to treat or help prevent future reactions. These medicines may include antihistamines, antipyretics (for treating fever), and corticosteroids.
If the infusion-related reaction is severe, your doctor will stop the intravenous infusion immediately and start giving you appropriate medical treatment.
Most of the time, you can still be given VPRIV even if these symptoms occur.
Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.
The following may interact with VPRIV:
There is no known interaction of VPRIV with other medicines.
How to take VPRIV:
Treatment with VPRIV should be supervised by a physician or other experienced health care provider.
After reconstitution, VPRIV has to be diluted in 100 mL 0.9% sodium chloride solution before use. After dilution VPRIV is given through a vein (drip feed).
Usual dose:
The usual dose is an infusion of 60 U/kg. Doses less than 60 U/kg also have been used (15 U/kg up to 60 U/kg). The infusion will normally last for 1 hour and will be given every other week.
Overdose:
If you think you have taken too much VPRIV, contact your health care professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.
Missed Dose:
If you have missed a dose, please contact your doctor.
What are possible side effects from using VPRIV?
Like all medicines, VPRIV can cause side effects, although not everybody experiences them. These are not all the possible side effects you may feel when taking VPRIV. If you experience any side effects not listed here, contact your healthcare professional.
Most side effects are mild to moderate and generally are associated with the infusion; however some side effects may be serious and may need treatment. Over time the number of these infusion-related reactions generally decreases. If you have any of these side effects talk to your doctor immediately.
Very common side effects (more than 1 per 10 patients) are:
- Headache
- Dizziness
- Bone pain
- Back pain
- Abdominal pain
- Infusion-related reaction
- Weakness/loss of strength/fatigue
- Fever/body temperature increased
- Colds and coughs
Common side effects (more than 1 per 100 patients) are:
- Nausea
- Decreased blood pressure
- Increased blood pressure
- Neutralizing antibody positive
- Flushing
- Rapid heart beat
In clinical trials, the most serious adverse reactions observed were allergic reactions. If you have an allergic reaction following administration of VPRIV, contact your doctor immediately.
Serious side effects and what to do about them
| Symptom / effect | Talk to your healthcare professional | Stop taking drug and get immediate medical help | |
|---|---|---|---|
| Only if severe | In all cases | ||
VERY COMMON Arthralgia: Joint Pain | |||
COMMON Hypersensitivity Reactions | |||
| Urticaria: Rash/Hives | |||
UNKNOWN* Anaphylactic Reaction: severe allergic reaction | |||
| Chest Discomfort | |||
| Dyspnea: Trouble Breathing | |||
| Pruritis: Itchy Skin | |||
| Vomiting |
*Frequency of event cannot be determined from available data.
If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.
Reporting Side Effects
You can report any suspected side effects associated with the use of health products to Health Canada by:
NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice. |
Storage:
Keep out of reach and sight of children. Store under refrigeration at 2°C to 8°C (36°F to 46°F) in the original outer packaging. Do not freeze. Protect from light. Do not use after the expiration date on the vial.
If you want more information about VPRIV:
- Talk to your healthcare professional
- Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website (http://hc-sc.gc.ca/index-eng.php); the manufacturer’s website (www.takeda.com/en-ca), or by calling 1-800-268-2772.
Takeda Canada Inc.
22 Adelaide Street West, Suite 3800
Toronto Ontario M5H 4E3
Last Revised December 21, 2020
VPRIV® and the VPRIV Logo® are registered trademarks of Shire Human Genetic Therapies, Inc.
TAKEDA™ and the TAKEDA Logo® are trademarks of Takeda Pharmaceutical Company Limited, used under license.
